Archive: 12/08/2013

New IBS treatment shows potential in Phase 2 study

Patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, treated with eluxadoline achieved better clinical response and experienced more symptom improvement than those using placebo, according to a recent study ...

New clue on the origin of Huntington's disease

The synapses in the brain act as key communication points between approximately one hundred billion neurons. They form a complex network connecting various centres in the brain through electrical impulses. New research from ...

page 5 from 8